While research on MVs or large EVs in PDAC remains limited, a recent paper has been published, linking glypican-1 mRNA expression in EXOs and protein levels in tumor-associated MVs, presenting a dual biomarker signature for PDAC. The gene discussed is GPC1; the disease is neoplasm.